...
首页> 外文期刊>Journal of otolaryngology - head & neck surgery = >Percutaneous endoscopic gastrostomy site metastasis from head and neck squamous cell carcinoma: case series and literature review
【24h】

Percutaneous endoscopic gastrostomy site metastasis from head and neck squamous cell carcinoma: case series and literature review

机译:头颈部鳞状细胞癌的经皮内镜胃造口术部位转移:病例系列及文献复习

获取原文

摘要

Objectives To present our experience with head and neck squamous cell carcinoma (HNSCC) seeding of percutaneous endoscopic gastrostomy (PEG) sites and to review all reported cases to identify risk factors and develop strategies for complication avoidance. Materials and methods The records of 4 patients with PEG site metastasis from HNSCC were identified from the authors’ institution. Thirty-eight further cases were reviewed following a PubMed search and evaluation of references in pertinent articles. Results Review of 42 cases revealed the average time from PEG to diagnosis of metastatic disease to be 8 months. Average time to death from detection of PEG disease was 5.9 months. One-year survival following PEG metastasis was 35.5% with an overall mortality of 87.1%. Conclusion PEG site metastatic disease portends a poor prognosis. Early detection and aggressive therapy may provide a chance of cure. Changes in PEG technique or in timing of adjunctive therapies are possible avenues in further research to prevent this complication.
机译:目的介绍我们在头颈鳞状细胞癌(HNSCC)播种经皮内镜下胃造瘘术(PEG)部位的经验,并回顾所有报道的病例,以确定危险因素并制定避免并发症的策略。资料与方法从作者所在的机构中确认了4例HNSCC发生PEG部位转移的患者的记录。在PubMed搜索并评估了相关文章中的参考文献之后,对另外38例病例进行了审查。结果回顾42例病例,发现从PEG到诊断出转移性疾病的平均时间为8个月。从发现PEG疾病到死亡的平均时间为5.9个月。 PEG转移后的一年生存率为35.5%,总死亡率为87.1%。结论PEG位点转移性疾病预后不良。早期发现和积极治疗可能会提供治愈的机会。 PEG技术或辅助治疗时机的改变是防止这种并发症的进一步研究的可能途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号